Status:
COMPLETED
Motion Analysis in Sacroiliac Joint Dysfunction
Lead Sponsor:
Zuyderland Medisch Centrum
Collaborating Sponsors:
Zuyd University of Applied Sciences
Conditions:
Sacroiliac Joint Dysfunction
Eligibility:
FEMALE
18-50 years
Brief Summary
Rationale: The sacroiliac joint (SIJ) is increasingly being recognized as a potential cause of chronic low back and buttock pain. The SIJ is affected in 14-22% in patients presenting with this pain. C...
Detailed Description
1.2 RATIONALE The sacroiliac joint (SIJ) is an anatomic structure that is increasingly being recognized as a potential cause of chronic low back and buttock pain. The SIJ is affected in 14-22% in pati...
Eligibility Criteria
Inclusion
- Inclusion criteria for participating clients in the healthy study group:
- \- Healthy individuals under the age of 25, with no history of SI dysfunction or lower back related illnesses
- Inclusion criteria for participating clients in the healthy study group with the same demographic characteristics as the SI dysfunction patients:
- \- Healthy individuals between the age of 25 and 45, female sex and postpartum with no history of SI dysfunction or lower back related illnesses
- Inclusion criteria for the MISJF group:
- The patient is suffering from SIJ dysfunction (uni- or bilateral) because of postpartum pelvic instability or because of Ehlers Danlos syndrome and is enlisted for primary MISJF surgery.
- The patient is mobile enough to perform several tests at the motion lab, needed to obtain spatiotemporal parameters, pelvic obliquity, center of gravity and load capacity.
- Exclusion criteria for all participating clients are:
- The individual is not mobile and/or unable to perform tests at the motion lab, needed to obtain spatiotemporal parameters, pelvic obliquity, center of gravity and load capacity.
- Inadequate command of the Dutch language.
- Age under 18 years.
Exclusion
Key Trial Info
Start Date :
March 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 30 2022
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04824534
Start Date
March 1 2021
End Date
December 30 2022
Last Update
August 22 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zuyderland MC
Heerlen, Limburg, Netherlands, 6419 PC